Triguero, A., Xicoy, B., Zamora, L., Jiménez, M., García, O., Calabuig, M., Díaz-Beyá, M., Arzuaga, J., Ramos, F., Medina, A., Bernal, T., Talarn, C., Coll, R., Collado, R., Chen, T., Borrás, J., Brunet, S., Marchante, I., Marco, V., López-Cadenas, F., Calbacho, M., Simiele, A., Cortés, M., Cedena, M., Pedreño, M., Aguilar, C., Pedró, C., Fernández, M., Stoica, C., Ribera, J., & Sanz, G. (2022). response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria. Leukemia research, 116, . http://access.bl.uk/ark:/81055/vdc_100153809941.0x000055